A Frailty Assessment Tool to Predict In-Hospital Mortality in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Background: The exacerbation of chronic obstructive pulmonary disease (AECOPD) is a chronic, frequent, and life-threatening lung disease. In 2014, a frailty index (FI) based on deficits in commonly used laboratory tests (FI-Lab) was suggested to identify older adults at increased risk of death.

Objective: We aim to study the prognostic value of the FI-Lab in older Chinese patients who were admitted because of AECOPD.

Efficient production and characterization of homopolymeric poly(3-hydroxyvalerate) produced by Bacillus strain PJC48.

Aliphatic polyester, poly(3-hydroxyvalerate) (PHV), is commonly produced as a granular component in bacterial cells of various species. Based on 16S rDNA gene sequence analysis, strain PJC48 was identified as a Bacillus species. The current study is aimed to screen for a high-yield strain that can produce PHV efficiently and to increase PHV product yield by optimizing the fermentative process.

Draft Genome Sequence of a Polydroxyalkanoate-Synthesizing Bacterium, sp. Strain PJC48, Isolated from Activated Sludge.

The genome sequence of a strain is capable of synthesizing polyhydroxyalkanoates, and sp. is considered a platform strain for the production of many biodegradable materials. Here, we present the sequence of the PJC48 strain genome, which is composed of three chromatin structures, an extracellular structure, and a cytoskeleton.

[Changes of plasma glucagon level in individuals with different glucose metabolism].

Objective: To determine the levels of plasma glucagon and associated factors in individuals with different glucose metabolism.

Methods: One hundred and ten outpatient patients received an oral glucose tolerance test (OGTT) voluntarily. The patients were divided into three groups according to their OGTT results: normal glucose golerance (NGT) group (n=33), impaired glucose regulation (IGR) group (n=35), newly diagnosed type 2 diabetes (DM2) group (n=42).

[New perspectives in the treatment of diabetes by interfering with glucagon signaling pathway].

Glucagon, a hormone secreted from the alpha cell of the endocrine pancreas, is a major counterpart to insulin. After released into blood, glucagon will combine with its receptor in targeting tissues and form a compound, which then activates its signaling pathway, produces cAMP, promotes gluconeogenesis and glycogenolysis and inventually increases blood glucose. Researches recently display that it will be an important addition to treatment method by inhibiting synthesis and secretion of glucagon, neutralizing circulating glucagon, using glucagon receptor antagonists and prohibiting gene expression of glucagon receptor.